Immunogenicity of bovine and leporine articular chondrocytes and meniscus cells

Tissue Engineering - Part A

Volumn 18, Issue 5-6, 2012, Pages 568-575

  Huey, Daniel J ^a   Sanchez Adams, Johannah ^a   Willard, Vincent P ^a   Athanasiou, Kyriacos A ^b  

^a Rice University   (United States)

^b University of California Davis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARTILAGE; CELLS; FACTOR ANALYSIS; FLOW CYTOMETRY; GRAFTS; MAMMALS; RNA; TISSUE; TISSUE ENGINEERING;

ARTICULAR CHONDROCYTES; CARTILAGE TISSUE ENGINEERING; CELL TYPES; COCULTURE; COSTIMULATION; ENGINEERED CARTILAGE; HYALINE CARTILAGE; IMMUNE REJECTION; IMMUNOGENICITY; IN-VITRO; IN-VIVO; ISOLATED CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS; MENISCAL CARTILAGES; MESSENGER RNA; PERIPHERAL BLOOD MONONUCLEAR CELLS; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION; SMALL ANIMAL MODEL; STIMULATE PROLIFERATION; XENOGENEIC CELLS;

CELL CULTURE;

ANIMALIA; BOVINAE;

B7 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BIOPROSTHESIS; CARTILAGE CELL; CATTLE; GRAFT REJECTION; HYALINE CARTILAGE; IMMUNOLOGY; KNEE MENISCUS; RABBIT; TISSUE ENGINEERING; TRANSPLANTATION; XENOGRAFT;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; BIOPROSTHESIS; CATTLE; CHONDROCYTES; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYALINE CARTILAGE; MENISCI, TIBIAL; RABBITS; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84857817161     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0226     Document Type: Article

References (62)

1. Buckwalter, J.A. Articular cartilage: injuries and potential for healing. J Orthop Sports Phys Ther 28, 192, 1998.
2. Adams, S.B., Jr., Randolph, M.A., and Gill, T.J. Tissue engineering for meniscus repair. J Knee Surg 18, 25, 2005.
3. Brindle, T., Nyland, J., and Johnson, D.L. The meniscus: review of basic principles with application to surgery and rehabilitation. J Athl Train 36, 160, 2001.
4. Greis, P.E., Bardana, D.D., Holmstrom, M.C., and Burks, R.T. Meniscal injury: I. Basic science and evaluation. J Am Acad Orthop Surg 10, 168, 2002.
5. Hoben, G.M., and Athanasiou, K.A. Meniscal repair with fibrocartilage engineering. Sports Med Arthrosc 14, 129, 2006.
6. Sweigart, M.A., and Athanasiou, K.A. Toward tissue engineering of the knee meniscus. Tissue Eng 7, 111, 2001.
7. Messner, K., and Gao, J. The menisci of the knee joint. Anatomical and functional characteristics, and a rationale for clinical treatment. J Anat 193 (Pt 2), 161, 1998.
8. Arnoczky, S.P. Gross and vascular anatomy of the meniscus and its role in meniscal healing, regeneration, and remodeling. In: Mow, V.C., Arnoczky, S.P., Jackson, D.W., eds. Knee Meniscus: Basic and Clinical Foundations. New York: Raven Press, 1992, pp. 6-12.
9. Aufderheide, A.C., and Athanasiou, K.A. Assessment of a bovine co-culture, scaffold-free method for growing meniscus-shaped constructs. Tissue Eng 13, 2195, 2007.
10. Elder, B.D., and Athanasiou, K.A. Hydrostatic pressure in articular cartilage tissue engineering: from chondrocytes to tissue regeneration. Tissue Eng Part B Rev 15, 43, 2009.
11. Gunja, N.J., and Athanasiou, K.A. Additive and synergistic effects of bFGF and hypoxia on leporine meniscus cell-seeded PLLA scaffolds. J Tissue Eng Regen Med 4, 115, 2010.
12. Medawar, P.B. The behaviour and fate of skin autografts and skin homografts in rabbits. J Anat 78, 176, 1944.
13. Fangmann, J., Dalchau, R., and Fabre, J.W. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. Transplant Proc 25, 183, 1993.
14. Turka, L.A., Linsley, P.S., Lin, H., Brady, W., Leiden, J.M. Wei, R.Q., Gibson, M., Zheng, X.G., Myrdal, S., Gordon, D., Bailey, T., Bolling, S.F., and Thompson, C.B. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 89, 11102, 1992.
15. Trivedi, H.L. Immunobiology of rejection and adaptation. Transplant Proc 39, 647, 2007.
16. Bretscher, P.A. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci USA 96, 185, 1999.
17. Kindt, T.J., Goldsby, R.A., Osborne, B.A., and Kuby, J. Kuby Immunology, 6th Ed. New York: W.H. Freeman, 2007.
18. Aston, J.E., and Bentley, G. Repair of articular surfaces by allografts of articular and growth-plate cartilage. J Bone Joint Surg Br 68, 29, 1986.
19. Backdahl, M., Consiglio, V., and Falconer, B. Reconstruction of the external ear with the use of maternal cartilage; a follow-up investigation of twenty-five cases. Br J Plast Surg 7, 263, 1954.
20. Burks, R.T., Greis, P.E., Arnoczky, S.P., and Scher, C. The use of a single osteochondral autograft plug in the treatment of a large osteochondral lesion in the femoral condyle-an experimental study in sheep. Am J Sport Med 34, 247, 2006.
21. Chesterman, P.J., and Smith, A.U. Homotransplantation of articular cartilage and isolated chondrocytes. An experimental study in rabbits. J Bone Joint Surg Br 50, 184, 1968.
22. Craigmyle, M.B. Antigenicity and survival of cartilage homografts. Nature 182, 1248, 1958.
23. Craigmyle, M.B. Cellular survival in long-term cartilage grafts in the rabbit. Transplant Bull 5, 123, 1958.
24. Adkisson, H.D., Milliman, C., Zhang, X., Mauch, K., Maziarz, R.T., and Streeter, P.R. Immune evasion by neocartilagederived chondrocytes: implications for biologic repair of joint articular cartilage. Stem Cell Res 4, 57, 2010.
25. Elves, M.W. A study of the transplantation antigens on chondrocytes from articular cartilage. J Bone Joint Surg Br 56, 178, 1974.
26. Jobanputra, P., Corrigall, V., Kingsley, G., and Panayi, G. Cellular responses to human chondrocytes: absence of allogeneic responses in the presence of HLA-DR and ICAM-1. Clin Exp Immunol 90, 336, 1992.
27. Ramallal, M., Maneiro, E., Lopez, E., Fuentes-Boquete, I., Lopez-Armada, M.J., Fernandez-Sueiro, J.L., Galdo, F., De Toro, F.J., and Blanco, F.J. Xeno-implantation of pig chondrocytes into rabbit to treat localized articular cartilage defects: an animal model. Wound Repair Regen 12, 337, 2004.
28. Yan, H., and Yu, C. Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy 23, 178, 2007.
29. van Susante, J.L., Buma, P., Schuman, L., Homminga, G.N., van den Berg, W.B., and Veth, R.P. Resurfacing potential of heterologous chondrocytes suspended in fibrin glue in large full-thickness defects of femoral articular cartilage: an experimental study in the goat. Biomaterials 20, 1167, 1999.
30. Heatley, F.W., and Revell, W.J. The use of meniscal fibrocartilage as a surface arthroplasty to effect the repair of osteochondral defects-an experimental study. Biomaterials 6, 161, 1985.
31. Revell, C.M., and Athanasiou, K.A. Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects. Tissue Eng Part B Rev 15, 1, 2009.
32. Hu, J.C., and Athanasiou, K.A. A self-assembling process in articular cartilage tissue engineering. Tissue Eng 12, 969, 2006.
33. Hoben, G.M., Hu, J.C., James, R.A., and Athanasiou, K.A. Selfassembly of fibrochondrocytes and chondrocytes for tissue engineering of the knee meniscus. Tissue Eng 13, 939, 2007.
34. Elder, B.D., and Athanasiou, K.A. Effects of temporal hydrostatic pressure on tissue-engineered bovine articular cartilage constructs. Tissue Eng Part A 15, 1151, 2009.
35. Gunja, N.J., Huey, D.J., James, R.A., and Athanasiou, K.A. Effects of agarose mould compliance and surface roughness on self-assembled meniscus-shaped constructs. J Tissue Eng Regen Med 3, 521, 2009.
36. Huey, D.J., and Athanasiou, K.A. Maturational growth of self-assembled, functional menisci as a result of TGF-beta1 and enzymatic chondroitinase-ABC stimulation. Biomaterials 32, 2052, 2011.
37. Muul, L.M., Silvin, C., James, S.P., and Candotti, F. Measurement of proliferative responses of cultured lymphocytes. Curr Protoc Immunol Chapter 7, Unit 7, 24, 2008.
38. Darling, E.M., and Athanasiou, K.A. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res 23, 425, 2005.
39. Ashrafi, G.H., Tsirimonaki, E., Marchetti, B., O'Brien, P.M., Sibbet, G.J., Andrew, L., and Saveria Campo, M. Downregulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21, 248, 2002.
40. Cannon, M.J., Davis, J.S., and Pate, J.L. The class II major histocompatibility complex molecule BoLA-DR is expressed by endothelial cells of the bovine corpus luteum. Reproduction 133, 991, 2007.
41. Donaldson, L., Vuocolo, T., Gray, C., Strandberg, Y., Reverter, A., and McWilliam, S., Wang, Y.H., Byrne, K., and Tellam, R. Construction and validation of a bovine innate immune microarray. BMC Genomics 6, 135, 2005.
42. Moreno, R., Martinez-Gonzalez, I., Rosal, M., Farwati, A., Gratacos, E., and Aran, J.M. Characterization of mesenchymal stem cells isolated from the rabbit fetal liver. Stem Cells Dev 19, 1579, 2010.
43. Alsalameh, S., Mollenhauer, J., Hain, N., Stock, K.P., Kalden, J.R., and Burmester, G.R. Cellular immune response toward human articular chondrocytes. T cell reactivities against chondrocyte and fibroblast membranes in destructive joint diseases. Arthritis Rheum 33, 1477, 1990.
44. Kuhne, M., Erben, U., Schulze-Tanzil, G., Kohler, D., Wu, P., Richter, F.J., John, T., Radbruch, A., Sieper, J., and Appel, H. HLA-B27-restricted antigen presentation by human chondrocytes to CD8+ T cells: potential contribution to local immunopathologic processes in ankylosing spondylitis. Arthritis Rheum 60, 1635, 2009.
45. Klareskog, L., Johnell, O., Hulth, A., Holmdahl, R., and Rubin, K. Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 29, 730, 1986.
46. Lance, E.M., Kimura, L.H., and Manibog, C.N. The expression of major histocompatibility antigens on human articular chondrocytes. Clin Orthop Relat Res 266, 1993.
47. Apte, S.S., and Athanasou, N.A. An immunohistological study of cartilage and synovium in primary synovial chondromatosis. J Pathol 166, 277, 1992.
48. Goldring, M.B., Sandell, L.J., Stephenson, M.L., and Krane, S.M. Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes. J Biol Chem 261, 9049, 1986.
49. Khoury, M.A., Goldberg, V.M., and Stevenson, S. Demonstration of HLA and ABH antigens in fresh and frozen human menisci by immunohistochemistry. J Orthop Res 12, 751, 1994.
50. Maier, D., Braeun, K., Steinhauser, E., Ueblacker, P., Oberst, M., Kreuz, P.C., Roos, N., Martinek, V., and Imhoff, A.B. In vitro analysis of an allogenic scaffold for tissue-engineered meniscus replacement. J Orthop Res 25, 1598, 2007.
51. Rodeo, S.A., Seneviratne, A., Suzuki, K., Felker, K., Wickiewicz, T.L., and Warren, R.F. Histological analysis of human meniscal allografts. A preliminary report. J Bone Joint Surg Am 82-A, 1071, 2000.
52. Fleischer, J., Soeth, E., Reiling, N., Grage-Griebenow, E., Flad, H.D., and Ernst, M. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology 89, 592, 1996.
53. Gaspari, A.A., Burns, R., Nasir, A., Ramirez, D., Barth, R.K., and Haidaris, C.G. CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections. Infect Immun 66, 4440, 1998.
54. Hathcock, K.S., Laszlo, G., Pucillo, C., Linsley, P., and Hodes, R.J. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180, 631, 1994.
55. Kano, M., Bashuda, H., Yagita, H., Okumura, K., and Morishita, Y. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice. Transplantation 65, 837, 1998.
56. Okano, M., Azuma, M., Yoshino, T., Hattori, H., Nakada, M., Satoskar, A.R., Harn, D.A., Jr, Nakayarna, E., Akagi, T., and Nishizaki, Y. Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice. Am J Respir Crit Care Med 164, 1501, 2001.
57. Perrin, P.J., Davis, T.A., Smoot, D.S., Abe, R., June, C.H., and Lee, K.P. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation. Immunology 90, 534, 1997.
58. Tatsumi, T., Takehara, T., Katayama, K., Mochizuki, K., Yamamoto, M., Kanto, T., Sasaki, Y., Kasahara, A., and Hayashi, N. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Hepatology 25, 1108, 1997.
59. Setoguchi, K., Misaki, Y., Kawahata, K., Shimada, K., Juji, T., Tanaka, S., Oda, H., Shukunami, C., Nishizaki, Y., Hiraki, Y., and Yamamoto, K. Suppression of T cell responses by chondromodulin I, a cartilage-derived angiogenesis inhibitory factor-therapeutic potential in rheumatoid arthritis. Arthritis Rheum 50, 828, 2004.
60. Bodmer, S., Strommer, K., Frei, K., Siepl, C., Detribolet, N., Heid, I., and Fontana, A. Immunosuppression and transforming growth factor-beta in glioblastoma-preferential production of transforming growth factor-beta 2. J Immunol 143, 3222, 1989.
61. Wahl, S.M., McCartney-Francis, N., and Mergenhagen, S.E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 10, 258, 1989.
62. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., Griganti, S., and Gianni, A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838, 2002.